Do you have a new product, new business focus, or a company to showcase? Increase your exposure with a Business Insight in PharmaTimes Magazine. Our flexible package means you can submit your own copy ...
The partnership will provide six MRC clinical fellows with industry placement opportunities The Medical Research Council (MRC) and pharmaceutical company AstraZeneca (AZ) have partnered to provide six ...
A new technology developed by researchers from King’s College London (KCL) could provide a new way of delivering drugs to advance next-generation treatments to prevent and treat a variety of diseases.
The National Institute for Health and Care Research (NIHR) has awarded an NIHR HealthTech Research Centre (HRC) Network £5m ...
Vicore Pharma and Endeavor BioMedicines have shared new data from two mid-stage clinical trials of two therapies that show promise in treating patients living with idiopathic pulmonary fibrosis (IPF).
Areas include health research across life stages, from paediatrics to health ageing and resilience The University of Liverpool and McMaster University have announced an institutional strategic ...
Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-MIT Alliance for Research and Technology (SMART), in collaboration with the Massachusetts ...
Researchers from Imperial College London (ICL), the Alan Turing Institute and the Universities of Sheffield and Nottingham are aiming to develop and test the first-ever ‘digital twin’ heart models for ...
The autoimmune disease, which affects 1.5 million people in the US, causes the body's immune system to attack its own tissues Researchers from Johns Hopkins Medicine have revealed that certain ...
The condition is the ninth most common cancer in the UK and affects 12,300 people annually The National Institute for Health and Care Research (NIHR) and the Tessa Jowell Brain Cancer Mission (TJBCM) ...
A new analysis led by the UK Health Security Agency (UKHSA) and Imperial College London (ICL) has confirmed that a variant called M1UK played a key role in the global increase of group A Streptococcus ...
Heart failure is a cardiovascular disease that affects more than 64 million people worldwide A study led by researchers from the University of Glasgow has revealed that a brand-new heart failure ...